Purpose: Many people with scleroderma rely on peer-led support groups as a coping resource. Reasons for not attending support groups in scleroderma have been investigated only in North American participants. This study assesses reasons for nonattendance in European countries and compares results with previously published North American findings. Materials and Methods: The same 21-item survey as used in the North American sample assessed possible reasons for not attending scleroderma support groups. Proportions of items rated Important or Very Important were compared between samples. Results: Consistent with the North American survey findings (N = 242), the two items most commonly rated as (Very) Important reasons for nonattendance among 228...
OBJECTIVES: To assess health care utilisation in Dutch patients with systemic sclerosis (SSc) and it...
Item does not contain fulltextOBJECTIVES: Knowledge about the nature and impact of symptoms faced by...
OBJECTIVES: Characteristics of Swiss patients with systemic sclerosis have not been described so far...
Objective: Peer-led support groups are an important resource for many people with scleroderma (syste...
Item does not contain fulltextPurpose: The objectives were to identify reasons why patients attend s...
Item does not contain fulltextPeer-facilitated support groups are an important source for receiving ...
Item does not contain fulltextPurpose: Systemic sclerosis or scleroderma is a chronic, rare connecti...
Background: Scleroderma is a chronic disorder, characterized by thickening and fibrosis of the skin ...
<p><b>Purpose:</b> Systemic sclerosis or scleroderma is a chronic, rare connective tissue disease wi...
PURPOSE: To evaluate the importance of different challenges experienced by informal caregivers to pe...
BACKGROUND:Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with ...
Item does not contain fulltextInvolving patients and health care professionals in research has been ...
Item does not contain fulltextOBJECTIVES: To assess health care utilisation in Dutch patients with s...
Background: Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with...
BACKGROUND/ OBJECTIVE: To gain insight in the use of current systemic sclerosis (SSc) care provided ...
OBJECTIVES: To assess health care utilisation in Dutch patients with systemic sclerosis (SSc) and it...
Item does not contain fulltextOBJECTIVES: Knowledge about the nature and impact of symptoms faced by...
OBJECTIVES: Characteristics of Swiss patients with systemic sclerosis have not been described so far...
Objective: Peer-led support groups are an important resource for many people with scleroderma (syste...
Item does not contain fulltextPurpose: The objectives were to identify reasons why patients attend s...
Item does not contain fulltextPeer-facilitated support groups are an important source for receiving ...
Item does not contain fulltextPurpose: Systemic sclerosis or scleroderma is a chronic, rare connecti...
Background: Scleroderma is a chronic disorder, characterized by thickening and fibrosis of the skin ...
<p><b>Purpose:</b> Systemic sclerosis or scleroderma is a chronic, rare connective tissue disease wi...
PURPOSE: To evaluate the importance of different challenges experienced by informal caregivers to pe...
BACKGROUND:Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with ...
Item does not contain fulltextInvolving patients and health care professionals in research has been ...
Item does not contain fulltextOBJECTIVES: To assess health care utilisation in Dutch patients with s...
Background: Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with...
BACKGROUND/ OBJECTIVE: To gain insight in the use of current systemic sclerosis (SSc) care provided ...
OBJECTIVES: To assess health care utilisation in Dutch patients with systemic sclerosis (SSc) and it...
Item does not contain fulltextOBJECTIVES: Knowledge about the nature and impact of symptoms faced by...
OBJECTIVES: Characteristics of Swiss patients with systemic sclerosis have not been described so far...